Inventor
MYERS MICHAEL C
US14 patents
⚠️ This page may combine multiple inventors who share the name “MYERS MICHAEL C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
12 patentsUS10266578B2Apr 23, 2019
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
BRISTOL MYERS SQUIBB CO9 citations82
US10106528B2Oct 23, 2018
6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists
BRISTOL MYERS SQUIBB CO3 citations71
US10011594B2Jul 3, 2018
4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists
BRISTOL MYERS SQUIBB CO4 citations71
US12168655B2Dec 17, 2024
Apelin receptor agonists and methods of use
BRISTOL MYERS SQUIBB CO0 citations62
US11390616B2Jul 19, 2022
Apelin receptor agonists and methods of use
BRISTOL MYERS SQUIBB CO1 citations62
US12097241B2Sep 24, 2024
Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides
BRISTOL MYERS SQUIBB CO0 citations61
US12097242B2Sep 24, 2024
Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides
BRISTOL MYERS SQUIBB CO0 citations61
US11364281B2Jun 21, 2022
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof
BRISTOL MYERS SQUIBB CO0 citations61
US11185570B2Nov 30, 2021
Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides
BRISTOL MYERS SQUIBB CO0 citations61
US10590113B2Mar 17, 2020
6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists
BRISTOL MYERS SQUIBB CO0 citations51
US10669261B2Jun 2, 2020
Heteroarylhydroxypyrimidinones as agonists of the APJ receptor
BRISTOL MYERS SQUIBB CO0 citations40
US10392347B2Aug 27, 2019
2,4-dihydroxy-nicotinamides as APJ agonists
BRISTOL MYERS SQUIBB CO0 citations40